Sonny Valindra
Ultrahuman, the Indian startup renowned for its sophisticated smart rings, has successfully closed a significant funding round, amassing $70 million. This substantial capital infusion, which includes strategic backing from Qualcomm’s venture arm, signals Ultrahuman’s ambitious pivot beyond conventional sleep and health tracking. The company is now focused on developing a new generation of smart rings capable of running on-device software, envisioning them as platforms that could power everything from intricate AI interactions to engaging gaming experiences. This latest funding round propels Ultrahuman’s valuation to an impressive $365 million, a threefold increase from its $120 million valuation in 2023, according to sources familiar with the matter.
The financing round saw participation from a formidable consortium of investors. Qualcomm Ventures, the venture capital arm of the global leader in mobile chip technology, joined U.S. diagnostics powerhouse Labcorp, alongside prominent investment firms Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital. Ultrahuman founder and CEO Mohit Kumar confirmed in an interview that the total funding comprises $65 million in primary equity and $5 million in debt.
A key component of this strategic investment is the ongoing collaboration between Ultrahuman and Qualcomm. Kumar revealed that the two companies are actively working on a new smart ring engineered to leverage Qualcomm’s cutting-edge silicon. While Ultrahuman’s current rings utilize chips from Nordic Semiconductor and will continue to do so, the integration of Qualcomm’s technology promises a significant leap in processing power. This enhanced computational capability will enable more sophisticated software and complex algorithms to operate directly on the ring itself, thereby diminishing its dependence on tethering to a smartphone or relying solely on cloud processing.
"All ring devices today are like trackers," Kumar articulated, highlighting the current market paradigm. "You put on the ring, it measures your heart rate, your movement, your sleep." Ultrahuman’s vision, however, is to transcend this limitation, transforming the smart ring into a versatile computing device where applications and algorithms can be executed locally. This evolution is poised to unlock a vast array of use cases far beyond its current health and sleep monitoring functionalities, which have become synonymous with Ultrahuman rings.
The implications of this on-device processing power are far-reaching. Developers could eventually be empowered to create custom applications for the ring, expanding its utility exponentially. Ultrahuman is actively exploring innovative applications, such as using the ring as a precise pointing device or a wireless mouse, a responsive game controller, a digital car key, and an intuitive interface for interacting with artificial intelligence systems.
Quinn Li, Global Head of Qualcomm Ventures, expressed enthusiasm for Ultrahuman’s trajectory, stating, "The future of AI is personal, ambient, and always on." He further emphasized Ultrahuman’s role in developing a new category of "personal AI devices." This sentiment underscores the strategic alignment between Qualcomm’s expertise in silicon and connectivity and Ultrahuman’s innovative approach to wearable technology.
While the Qualcomm-powered ring is slated for a future release, Ultrahuman is not waiting for new hardware to begin realizing its vision. Kumar disclosed that some of these advanced capabilities will be rolled out to existing Ultrahuman models, including the Ring Air and Ring Pro, via a software update expected by the end of September. These updates will introduce features enabling the ring to function as a game controller and to interact with AI applications. Crucially, these enhancements will also pave the way for third-party developers to contribute new functionalities, fostering a vibrant ecosystem around the Ultrahuman platform.
Kumar elaborated on the unique positional advantage of a ring worn on the finger. He contrasted it with smartwatches, which he characterized as akin to "a phone on the wrist." A ring, on the other hand, offers the potential for highly precise interaction and pointing, coupled with the continuous collection of vital physiological data such as heart rate, body temperature, and movement patterns. This dual capability opens up novel possibilities, as Kumar illustrated with the concept of immersive gaming experiences where the ring acts not only as a controller responding to physical movements but also as a sensor providing real-time physiological feedback. "A game controller never reads your heart rate and your temperature, but this one does," he remarked, underscoring the unique value proposition.
The Business Behind the Bet: Robust Growth Fuels Ambitious Expansion
While Ultrahuman is charting an ambitious course for the future of its smart rings, its existing business is demonstrating remarkable resilience and growth. The company currently boasts an annual revenue run rate of $140 million, representing a significant increase of approximately 45% compared to the previous year. Ultrahuman projects this run rate to reach $200 million by January 2027. To date, the company has sold around 800,000 rings, a notable increase from approximately 700,000 units reported in February. Furthermore, a segment of its user base, around 12%, subscribes to Ultrahuman’s premium software features offered through its "PowerPlugs" subscription service.
Founded in 2019 by Mohit Kumar and Vatsal Singhal, Ultrahuman initially focused on continuous glucose monitors (CGMs) to assist individuals in managing their metabolic health. The company later strategically shifted its primary focus to smart rings, which have since become the cornerstone of its product portfolio. In its pursuit of a comprehensive health platform, Ultrahuman has also expanded its offerings to include blood testing services and environmental sensing capabilities.
The United States remains Ultrahuman’s largest market. However, the company faced a temporary setback in its U.S. sales of the Ring Air for a significant portion of the past year due to a patent dispute with its rival, Oura. Ultrahuman has since re-entered the U.S. market with its redesigned Ring Pro, a move that has been met with overwhelming demand. Kumar reported that demand for the new device is currently between 18 to 20 times the startup’s available supply in the U.S. The company anticipates returning to its previous sales volumes in the U.S. as early as the next quarter and aims to triple those volumes over the subsequent four quarters as production scales up. Currently, the U.S. accounts for approximately 45% of Ultrahuman’s quarterly revenue, with India contributing about 11%.
A portion of the newly raised capital will be allocated to strengthening Ultrahuman’s presence in key international markets, including India and the United Arab Emirates. The company has observed that physical retail presence and other offline touchpoints have proven effective in driving sales in these regions. However, this expansion, coupled with investments in clinical research and product development, has impacted profitability. Kumar acknowledged that Ultrahuman may not achieve profitability in the current year due to increased expenditures in physical retail, brand building, and clinical studies.
Strategic Partnerships and Future Outlook
Unlike its competitor Oura, which is reportedly exploring an Initial Public Offering (IPO) in September, Ultrahuman’s path to a public listing is still some distance away. Kumar indicated that the company aims to demonstrate approximately eight quarters of sustained profitability before considering an IPO, a benchmark he anticipates will take eight to ten quarters to achieve. He identified 2028 as the earliest potential window for an IPO.
In parallel with its hardware and software development, Ultrahuman is deepening its collaboration with Labcorp. The two companies are investigating the potential of integrating the blood-flow signals captured by Ultrahuman’s rings with blood-test data. This synergy could lead to advanced health risk identification in areas such as cardiovascular health, fertility, and aging.
Megann Vaughn Watters, Vice President and Head of Labcorp Venture Fund and Strategic Alliances, commented on the partnership’s potential, stating, "By combining longitudinal wearable data with deeper biological signals, Ultrahuman is creating new opportunities in personalized health." While Kumar declined to provide specific details regarding potential integrations, he indicated that the startup anticipates making further announcements soon, suggesting a promising future for this health-focused collaboration. This strategic alliance with a major diagnostic player underscores Ultrahuman’s commitment to leveraging its wearable technology for more profound health insights and interventions, positioning itself at the forefront of the personalized health revolution.
